|
1
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carey LA, Perou CM, Livasy CA, Dressler
LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S,
et al: Race, breast cancer subtypes, and survival in the Carolina
Breast Cancer Study. JAMA. 295:2492–2502. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cronin KA, Harlan LC, Dodd KW, Abrams JS
and Ballard-Barbash R: Population-based estimate of the prevalence
of HER-2 positive breast cancer tumors for early stage patients in
the US. Cancer Invest. 28:963–968. 2010. View Article : Google Scholar
|
|
4
|
Slamon DJ, Clark GM, Wong SG, Levin WJ,
Ullrich A and McGuire WL: Human breast cancer: Correlation of
relapse and survival with amplification of the HER-2/neu oncogene.
Science. 235:177–182. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun M and Kraus WL: From discovery to
function: The expanding roles of long noncoding RNAs in physiology
and disease. Endocr Rev. 36:25–64. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ao X, Ding W, Li X, Xu Q, Chen X, Zhou X,
Wang J and Liu Y: Non-coding RNAs regulating mitochondrial function
in cardiovascular diseases. J Mol Med (Berl). 101:501–526. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen YG, Satpathy AT and Chang HY: Gene
regulation in the immune system by long noncoding RNAs. Nat
Immunol. 18:962–972. 2017. View
Article : Google Scholar
|
|
8
|
Liu Y, Ding W, Wang J, Ao X and Xue J:
Non-coding RNA-mediated modulation of ferroptosis in cardiovascular
diseases. Biomed Pharmacother. 164:1149932023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun M, Gadad SS, Kim DS and Kraus WL:
Discovery, annotation, and functional analysis of long noncoding
RNAs controlling cell-cycle gene expression and proliferation in
breast cancer cells. Mol Cell. 59:698–711. 2015. View Article : Google Scholar
|
|
10
|
Chen DQ, Zheng XD, Cao Y, HeX D, Nian WQ,
Zeng XH and Liu XY: Long non-coding RNA LINC00628 suppresses the
growth and metastasis and promotes cell apoptosis in breast cancer.
Eur Rev Med Pharmacol Sci. 21:275–283. 2017.
|
|
11
|
Jiang X, Zhou Y, Sun AJ and Xue JL: NEAT1
contributes to breast cancer progression through modulating miR-448
and ZEB1. J Cell Physiol. 233:8558–8566. 2018. View Article : Google Scholar
|
|
12
|
Ahmadpour ST, Orre C, Bertevello PS,
Mirebeau-Prunier D, Dumas JF and Desquiret-Dumas V: Breast cancer
chemoresistance: Insights into the regulatory role of lncRNA. Int J
Mol Sci. 24:158972023. View Article : Google Scholar
|
|
13
|
Denaro N, Merlano MC and Lo Nigro C: Long
noncoding RNAs as regulators of cancer immunity. Mol Oncol.
13:61–73. 2019. View Article : Google Scholar
|
|
14
|
Zhang L, Xu X and Su X: Noncoding RNAs in
cancer immunity: Functions, regulatory mechanisms, and clinical
application. Mol Cancer. 19:482020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shen Y, Peng X and Shen C: Identification
and validation of immune-related lncRNA prognostic signature for
breast cancer. Genomics. 112:2640–2646. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lingle W, Erickson BJ, Zuley ML, Jarosz R,
Bonaccio E, Filippini J, Net JM, Levi L, Morris EA, Figler GG, et
al: 2016.The Cancer Genome Atlas Breast Invasive Carcinoma
Collection (TCGA-BRCA) (Version 3) [Data set]. The Cancer Imaging
Archive. https://doi.org/10.7937/K9/TCIA.2016.AB2NAZRP
|
|
17
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hanley JA and McNeil BJ: The meaning and
use of the area under a receiver operating characteristic (ROC)
curve. Radiology. 143:29–36. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen B, Khodadoust MS, Liu CL, Newman AM
and Alizadeh AA: Profiling tumor infiltrating immune cells with
CIBERSORT. Methods Mol Biol. 1711:243–259. 2018. View Article : Google Scholar
|
|
20
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matkowski R, Gisterek I, Halon A, Lacko A,
Szewczyk K, Staszek U, Pudelko M, Szynglarewicz B, Szelachowska J,
Zolnierek A and Kornafel J: The prognostic role of
tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer.
Anticancer Res. 29:2445–2451. 2009.PubMed/NCBI
|
|
22
|
Yeo W, Chan SL, Mo FK, Chu CM, Hui JW,
Tong JH, Chan AW, Koh J, Hui EP, Loong H, et al: Phase I/II study
of temsirolimus for patients with unresectable Hepatocellular
Carcinoma (HCC)-a correlative study to explore potential biomarkers
for response. BMC Cancer. 15:3952015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Azim HA Jr, Peccatori FA, Brohée S,
Branstetter D, Loi S, Viale G, Piccart M, Dougall WC, Pruneri G and
Sotiriou C: RANK-ligand (RANKL) expression in young breast cancer
patients and during pregnancy. Breast Cancer Res. 17:242015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu W, Li X, Zhang C, Yang Y, Jiang J and
Wu C: Tumor-associated macrophages in cancers. Clin Transl Oncol.
18:251–258. 2016. View Article : Google Scholar
|
|
25
|
Xiong S, Dong L and Cheng L: Neutrophils
in cancer carcinogenesis and metastasis. J Hematol Oncol.
14:1732021. View Article : Google Scholar
|
|
26
|
Terry RL and Miller SD: Molecular control
of monocyte development. Cell Immunol. 291:16–21. 2014. View Article : Google Scholar
|
|
27
|
Miao X, Leng X and Zhang Q: The current
state of nanoparticle-induced macrophage polarization and
reprogramming research. Int J Mol Sci. 18:3362017. View Article : Google Scholar
|
|
28
|
Biswas SK and Mantovani A: Macrophage
plasticity and interaction with lymphocyte subsets: Cancer as a
paradigm. Nat Immunol. 11:889–896. 2010. View Article : Google Scholar
|
|
29
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA
Language? Cell. 146:353–358. 2011. View Article : Google Scholar
|
|
30
|
Maughan KL, Lutterbie MA and Ham PS:
Treatment of breast cancer. Am Fam Physician. 81:1339–1346.
2010.PubMed/NCBI
|
|
31
|
Yu T, Gan S, Zhu Q, Dai D, Li N, Wang H,
Chen X, Hou D, Wang Y, Pan Q, et al: Modulation of M2 macrophage
polarization by the crosstalk between Stat6 and Trim24. Nat Commun.
10:43532019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ghafouri-Fard S, Abak A, Tavakkoli Avval
S, Shoorei H, Taheri M and Samadian M: The impact of non-coding
RNAs on macrophage polarization. Biomed Pharmacother.
142:1121122021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zong S, Dai W, Guo X and Wang K:
LncRNA-SNHG1 promotes macrophage M2-like polarization and
contributes to breast cancer growth and metastasis. Aging (Albany
NY). 13:23169–23181. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li H, Jiang T, Li MQ, Zheng XL and Zhao
GJ: Transcriptional regulation of macrophages polarization by
MicroRNAs. Front Immunol. 9:11752018. View Article : Google Scholar
|
|
35
|
Sánchez-González I, Bobien A, Molnar C,
Schmid S, Strotbek M, Boerries M, Busch H and Olayioye MA: miR-149
suppresses breast cancer metastasis by blocking paracrine
interactions with macrophages. Cancer Res. 80:1330–1341. 2020.
View Article : Google Scholar
|
